Can probiotics change fish behavior?


Frank and her colleagues in Christina Semeniuk’s lab and comentor Daniel Heath’s lab at the University of Windsor in Ontario are trying to determine whether an unlikely intervention — a probiotic supplement in fish food — might help triploid Chinook salmon fare better. They’re starting with how the fish behave.
“Behavioral flexibility and sensitivity … would be an immediate measure for physiological (and neural genomic) change, given the connections between the gut–brain–behavior axis,” Semeniuk said.
Frank tested how probiotic supplements added to fish food affected the way hundreds of fingerling diploid and triploid fish respond to novel stimuli such as a glass bead tossed into the tank, a predator-shaped dummy passing overhead and an approaching human researcher. She will present her work as part of the Genomics poster session during the 2021 ASBMB annual meeting; you can see her talk and post questions while the meeting is underway.
In the future, Frank plans to integrate transcriptomic analyses with her behavioral studies, an approach known as behavioral genomics. Little is known about how triploidy affects genes related to learning and memory, so even if probiotics have little effect, she stands to learn something interesting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.